Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40KCH | ISIN: US00853E4044 | Ticker-Symbol:
NASDAQ
26.06.25 | 18:41
21,130 US-Dollar
0,00 % 0,000
1-Jahres-Chart
AGRIFY CORPORATION Chart 1 Jahr
5-Tage-Chart
AGRIFY CORPORATION 5-Tage-Chart

Aktueller Chart AGRIFY Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
AGRIFY CORPORATION-Investoren interessieren sich auch für diese Wertpapiere
EQS-News: Immunic AG: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple SclerosisIssuer: Immunic AG / Key word(s): Study/Study results Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in...
► Artikel lesen
EQS-News: Immunic AG: Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MSIssuer: Immunic AG / Key word(s): Study/Study results Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining...
► Artikel lesen
Immunic, Inc.: Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS- Enrollment Completed for Both Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Top-Line Data Expected End of 2026 - - Additional...
► Artikel lesen
Applied DNA Sciences, Inc.: Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. HaywardPresident and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"...
► Artikel lesen
Applied DNA Sciences: Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-AugustSTONY BROOK, NY / ACCESS Newswire / June 16, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume...
► Artikel lesen
XFRA NEW INSTRUMENTS AVAILABLE ON 02.06.2025The following instruments on XETRA do have their first trading 02.06.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.06.2025 Aktien 1 LU0445408270 Altisource Portfolio...
► Artikel lesen
Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace)Anzeige / WerbungAktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) Fundamentalanalyse trifft auf Charttechnik, so starteten wir diese Webinarreihe...
► Artikel lesen
XTI Aerospace, Inc.: President Trump's Executive Order Highlights the Strategic Importance of VTOL SectorXTI Aerospace expects Trump Executive Order to accelerate VTOL development for commercial and military applications ENGLEWOOD, Colo., June 10, 2025 /PRNewswire/ -- Commending President...
► Artikel lesen
XTI Aerospace, Inc.: XTI Aerospace Reports First Quarter 2025 Results and Provides Business UpdateBalance sheet strengthened through elimination of legacy debt and stock-based obligations Strong TriFan 600 program execution and FAA certification progress position...
► Artikel lesen